Print

CV Risk Remains High After Stopping Vioxx, Yale University School Of Medicine Study  
12/15/2010 6:28:03 AM

MedPageToday -- Even after patients stopped taking the painkiller rofecoxib (Vioxx) when it was pulled from the market, their risk of cardiovascular events remained high, researchers reported.